Literature DB >> 28783944

Electroconvulsive Therapy and Oxidative Stress: Comment on the Article of Şenyurt et al. (Clin Psychophacol Neurosci 2017;15:40-46).

Tevfik Kalelioglu1, Abdullah Genc2, Nesrin Karamustafalioglu1.   

Abstract

Entities:  

Year:  2017        PMID: 28783944      PMCID: PMC5565078          DOI: 10.9758/cpn.2017.15.3.298

Source DB:  PubMed          Journal:  Clin Psychopharmacol Neurosci        ISSN: 1738-1088            Impact factor:   2.582


× No keyword cloud information.
TO THE EDITOR We recently read with interest the article by Şenyurt et al. titled “Evaluation of Oxidative Status in Patients Treated with Electroconvulsive Therapy” published in February 2017 in this journal.1) The authors conducted a study suggesting that electroconvulsive therapy (ECT) has no negative effect on oxidative stress in terms of serum total oxidant status (TOS), total antioxidant status (TAS) and their ratio oxidative stress index (OSI). Even though the sub-groups have small sample size which may be inadequate for a statistically significance, they found that OSI levels were decreased significantly in schizophrenia, insignificantly in bipolar and major depressive groups after ECT when compared with pre-ECT levels.1) We would like to comment on this research. Despite the fact that this study has negative trial results which is also negative factor for publishing, we believe that it contributes valuable information as important as positive results in the growing evidence of the relation between ECT and oxidative stress. There are a limited number of clinical studies about effect of ECT on oxidative mechanisms.2–4) Besides evaluating the oxidant-antioxidant molecules individually, evaluating the total oxidant and antioxidant capacity may have a potential to reflect the status of whole system homeostasis. Hence, we think that this study has an advantage to reflect such an association between ECT and oxidative homeostasis. Antipsychotics are important therapeutic agents used in treatment of schizophrenia, bipolar disorder and also major depressive disorder. The authors state that the anti-psychotics have positive effects on oxidative stress. However, on contrary, preclinical and in-vitro studies demonstrate increased oxidative stress particularly with typical antipsychotics.5–7) Furthermore, in our previously published study, we evaluated serum TAS, TOS and OSI levels in manic state and alterations with the treatment modalities of ECT+antipsychotics or antipsychotics alone. Strikingly we have found that only antipsychotic group showed a significant increase in OSI levels whereas no significant change was observed in ECT+ antipsychotic group in terms of oxidative stress. As similar to above-mentioned studies, clinically we demonstrated that anti-psychotics might increase oxidative burden.8) Taken together, in concordance with the current study performed by Şenyurt et al.,1) our previous study has indicated that ECT may have positive or at least no additional influences on oxidative stress. Studies with larger samples and refined groups from effect of confounders are required to confirm these findings.
  8 in total

1.  Protective effect of Calligonum comosum on haloperidol-induced oxidative stress in rat.

Authors:  Essam A Abdel-Sattar; Samar M Mouneir; Gihan F Asaad; Hossam M Abdallah
Journal:  Toxicol Ind Health       Date:  2012-07-06       Impact factor: 2.273

2.  Initial and post-treatment total oxidant-antioxidant status and oxidative stress index in male patients with manic episode.

Authors:  Tevfik Kalelioglu; Abdullah Genc; Nesrin Karamustafalioglu; Akif Tasdemir; Ferda Can Gungor; Alparslan Cansiz; Said Incir; M Cem Ilnem; Murat Emul
Journal:  Psychiatry Res       Date:  2014-04-16       Impact factor: 3.222

3.  Acute and chronic effects of electroconvulsive treatment on oxidative parameters in schizophrenia patients.

Authors:  Sukru Kartalci; Aysun Bay Karabulut; Abdul Cemal Ozcan; Esra Porgali; Suheyla Unal
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2011-05-18       Impact factor: 5.067

4.  Quetiapine, olanzapine and haloperidol affect human plasma lipid peroxidation in vitro.

Authors:  Anna Dietrich-Muszalska; Bogdan Kontek; Jolanta Rabe-Jabłońska
Journal:  Neuropsychobiology       Date:  2011-03-22       Impact factor: 2.328

5.  Level of plasma thioredoxin in male patients with manic episode at initial and post-electroconvulsive or antipsychotic treatment.

Authors:  Abdullah Genc; Tevfik Kalelioglu; Nesrin Karamustafalioglu; Akif Tasdemir; Ferda Can Gungor; Esra Sena Genc; Said Incir; Cem Ilnem; Murat Emul
Journal:  Psychiatry Clin Neurosci       Date:  2014-11-14       Impact factor: 5.188

6.  Systemic oxidatively generated DNA/RNA damage in clinical depression: associations to symptom severity and response to electroconvulsive therapy.

Authors:  Anders Jorgensen; Jesper Krogh; Kamilla Miskowiak; Tom G Bolwig; Lars V Kessing; Anders Fink-Jensen; Merete Nordentoft; Trine Henriksen; Allan Weimann; Henrik E Poulsen; Martin B Jorgensen
Journal:  J Affect Disord       Date:  2013-03-13       Impact factor: 4.839

Review 7.  Haloperidol cytotoxicity and its relation to oxidative stress.

Authors:  Martina Raudenska; Jaromir Gumulec; Petr Babula; Tibor Stracina; Marketa Sztalmachova; Hana Polanska; Vojtech Adam; Rene Kizek; Marie Novakova; Michal Masarik
Journal:  Mini Rev Med Chem       Date:  2013-12       Impact factor: 3.862

8.  Evaluation of Oxidative Status in Patients Treated with Electroconvulsive Therapy.

Authors:  Mahmut Şenyurt; Hulya Aybek; Hasan Herken; Bunyamin Kaptanoglu; Ali Korkmaz
Journal:  Clin Psychopharmacol Neurosci       Date:  2017-02-28       Impact factor: 2.582

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.